Ratios Reveal: Breaking Down Corcept Therapeutics Inc (CORT)’s Financial Health

Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.

Corcept Therapeutics Inc (NASDAQ: CORT) closed the day trading at $69.60 up 0.85% from the previous closing price of $69.01. In other words, the price has increased by $0.85 from its previous closing price. On the day, 0.97 million shares were traded.

Ratios:

For a better understanding of CORT, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 22.87 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 41.66. For the most recent quarter (mrq), Quick Ratio is recorded 2.96 and its Current Ratio is at 3.07. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Truist on November 06, 2023, Upgraded its rating to Buy and sets its target price to $38 from $29 previously.

On April 11, 2023, SVB Securities started tracking the stock assigning a Market Perform rating and target price of $25.

On April 04, 2023, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $27.Piper Sandler initiated its Overweight rating on April 04, 2023, with a $27 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 02 ’25 when BELANOFF JOSEPH K sold 40,000 shares for $82.86 per share. The transaction valued at 3,314,310 led to the insider holds 2,901,985 shares of the business.

Lyon Joseph Douglas sold 5,000 shares of CORT for $390,218 on Jun 02 ’25. The insider now owns 9,009 shares after completing the transaction at $78.04 per share. On Jun 02 ’25, another insider, Maduck Sean, who serves as the insider of the company, sold 20,000 shares for $79.08 each. As a result, the insider received 1,581,686 and left with 17,705 shares of the company.

Valuation Measures:

As of this moment, Corcept’s Price-to-Earnings (P/E) ratio for their current fiscal year is 60.41, and their Forward P/E ratio for the next fiscal year is 26.17. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.87. For the stock, the TTM Price-to-Sale (P/S) ratio is 10.77 while its Price-to-Book (P/B) ratio in mrq is 10.80.

Stock Price History:

Over the past 52 weeks, CORT has reached a high of $117.33, while it has fallen to a 52-week low of $28.04. The 50-Day Moving Average of the stock is -4.23%, while the 200-Day Moving Average is calculated to be 20.95%.

Shares Statistics:

A total of 105.98M shares are outstanding, with a floating share count of 93.76M. Insiders hold about 11.58% of the company’s shares, while institutions hold 79.02% stake in the company.

Leave a Reply

Your email address will not be published. Required fields are marked *

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.